Ernexa Therapeutics is developing cell therapies for cancer and autoimmune diseases using engineered iPSCs transformed into iMSCs. Its scalable, allogeneic platform is designed as an off-the-shelf treatment without patient-specific harvesting.
Advertisement|Remove ads.